In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods

FEMS Immunology and Medical Microbiology

Volumn 58, Issue 2, 2010, Pages 193-201

  Guo, Na ^a   Wu, Xiuping ^a   Yu, Lu ^a   Liu, Jingbo ^a   Meng, Rizeng ^b   Jin, Jing ^a   Lu, Huijun ^a   Wang, Xuelin ^a   Yan, Shuhan ^a   Deng, Xuming ^a  

^a JILIN UNIVERSITY   (China)

^b Jilin Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Antifungal interactions; Antifungal susceptibility; Candida albicans

Indexed keywords

ALLICIN; FLUCONAZOLE; ANTIFUNGAL AGENT; SULFINIC ACID DERIVATIVE;

AGAR DIFFUSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL RESISTANCE; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG INTERACTION; DRUG POTENTIATION; FUNGAL STRAIN; FUNGUS ISOLATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NONPARAMETRIC TEST; PRIORITY JOURNAL; READING; SPECTROPHOTOMETRY; BACTERIAL COUNT; CANDIDIASIS; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROBIOLOGY; STATISTICAL MODEL; TIME;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, FUNGAL; DRUG SYNERGISM; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MODELS, STATISTICAL; SULFINIC ACIDS; TIME FACTORS;

EID: 76349101644     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2009.00620.x     Document Type: Article

References (38)

1. Afeltra J, Vitale RG, Mouton JW Verweij PE (2004) Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazole. Antimicrob Agents Ch 48 : 1335 1343.
2. Agarwal KC (1996) Therapeutic actions of garlic constituents. Med Res Rev 16 : 111 124.
3. An M, Shen H, Cao Y, Zhang J, Cai Y, Wang R Jiang Y (2009) Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. Int J Antimicrob Ag 33 : 258 263.
4. Ankri S Mirelman D (1999) Antimicrobial properties of allicin from garlic. Microbes Infect 1 : 125 129.
5. Benjamin DK Jr., Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, Duara S, Poole K, Laptook A Goldberg R (2006) Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117 : 84 92.
6. Davis SR, Perrie R Apitz-Castro R (2003) The in-vitro susceptibility of Scedosporium prolificans to ajoene, allitridium, and a raw extract of garlic (Allium sativum). J Antimicrob Chemoth 51 : 593 597.
7. Deng XL, Zhang XC, Zhang F, Li RY, Lu HJ, He WQ, Liu LG, Fan B Hu XY (2006) Cloning and sequencing of the GTP cyclohydrolase I function region of azole target enzyme gene in artificially induced resistant Candida albicans. Beijing Da Xue Xue Bao 38 : 301 304.
8. Eliopoulos GM Moellering RC Jr. (1996) Antimicrobial combinations. Antibiotics in Laboratory Medicine (Lorian V, ed), pp. 330 396. Williams & Wilkins Co., Baltimore.
9. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Fothergill A, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL Verweij PE (2005) Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study. J Clin Microbiol 43 : 4535 4540.
10. Georgopapadakou NH Tkacz JS (1995) The fungal cell wall as a drug target. Trends Microbiol 3 : 98 104.
11. Gozalbo D, Roig P, Villamón E Gil ML (2004) Candida and candidiasis: the cell wall as a potential molecular target for antifungal therapy. Curr Drug Targets Infect Disord 4 : 117 135.
12. Greco WR, Bravo G Parsons JC (1995) The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 47 : 331 385.
13. Guo Q, Sun S, Yu J, Li Y Cao L (2008) Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods. J Med Microbiol 57 : 457 462.
14. Hirsch K, Danilenko M, Giat J, Miron T, Rabinkov A, Wilchek M, Mirelman D, Levy J Sharoni Y (2000) Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer 38 : 245 254.
15. Klepser ME, Wolfe EJ, Jones RN, Nightingale CH Pfaller MA (1997) Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans. Antimicrob Agents Ch 41 : 1392 1395.
16. Li Y, Sun S, Guo Q, Ma L, Shi C, Su L Li H (2008) In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. J Antimicrob Chemoth 61 : 577 585.
17. Marchetti O, Moreillon P, Glauser MP, Bille J Sanglard D (2000) Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Ch 44 : 2373 2381.
18. Marchetti O, Moreillon P, Entenza JM, Vouillamoz J, Glauser MP, Bille J Sanglard D (2003) Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrob Agents Ch 47 : 1565 1570.
19. Meletiadis J, Mouton JW, Meis JF Verweij PE (2003) In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Ch 47 : 106 117.
20. Miron T, Rabinkov A, Mirelman D, Wilchek M Weiner L (2000) The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim Biophys Acta 1463 : 20 30.
21. Nooney L, Matthews RC Burnie JP (2005) Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies. Diagn Micr Infec Dis 51 : 19 29.
22. Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemoth 52 : 1.
23. Ogita A, Fujita K, Taniguchi M Tanaka T (2006) Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system. Planta Med 72 : 1247 1250.
24. Pfaller MA, Sheehan DJ Rex JH (2004) Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev 17 : 268 280.
25. Prichard MN, Prichard LE Shipman C Jr. (1993) Strategic design and three-dimensional analysis of antiviral drug combinations. Antimicrob Agents Ch 37 : 540 545.
26. Pyun MS Shin S (2006) Antifungal effects of the volatile oils from Allium plants against Trichophyton species and synergism of the oils with ketoconazole. Phytomedicine 13 : 394 400.
27. Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF Jiang YY (2006) Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Ch 50 : 1096 1099.
28. Rabinkov A, Miron T, Mirelman D, Wilchek M, Glozman S, Yavin E Weiner L (2000) S-Allylmercaptoglutathione: the reaction product of allicin with glutathione possesses SH-modifying and antioxidant properties. Biochim Biophys Acta 1499 : 144 153.
29. Sanglard D, Ischer F, Parkinson T, Falconer D Bille J (2003) Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Ch 47 : 2404 2412.
30. Sroussi HY, Köhler GA, Agabian N, Villines D Palefsky JM (2009) Substitution of methionine 63 or 83 in S100A9 and cysteine 42 in S100A8 abrogate the antifungal activities of S100A8/A9: potential role for oxidative regulation. FEMS Immunol Med Mic 55 : 55 61.
31. Sun L, Sun S, Cheng A, Wu X, Zhang Y Lou H (2009) In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrob Agents Ch 53 : 1586 1591.
32. Sun S, Li Y, Guo Q, Shi C, Yu J Ma L (2008) In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. Antimicrob Agents Ch 52 : 409 417. (Pubitemid 351170807)
33. Tariq VN, Scott EM McCain NE (1995) Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro. Antimicrob Agents Ch 39 : 2615 2619.
34. Uppuluri P, Nett J, Heitman J Andes D (2008) Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Ch 52 : 1127 1132.
35. Vanden Bossche H (1985) Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. Curr Top Med Mycol 1 : 313 351.
36. Van t Wout JW, Mattie H van Furth R (1989) Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrob Agents Ch 33 : 147 151.
37. Viudes A, Pemán J, Cantón E, Ubeda P, López-Ribot JL Gobernado M (2002) Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol 21 : 767 774.
38. White TC, Holleman S, Dy F, Mirels LF Stevens DA (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Ch 46 : 1704 1713.